What does Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company pay?
Median total pay is about $212,500 per year, with most roles between $193,750 and $272,500 — based on salary ranges disclosed in Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company's own job postings.
$212,500
Median total pay
$193,750
25th percentile
$272,500
75th percentile
11
Posted salaries
Highest-paying roles at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company
Executive Director, Clinical Development
$340,000–$380,000
Executive Director, Toxicology
$270,000–$300,000
Senior Director, Clinical Pharmacology
$275,000–$295,000
Senior Director, Patient Advocacy
$240,000–$275,000
Senior Director, Toxicology (CNS Specialist)
$250,000–$270,000
Director, CMC Program Management - Drug Product
$200,000–$225,000
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company salary FAQ
What is the median salary at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company?
Based on 11 salaried US roles currently posted, the median total pay at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company is about $212,500 per year.
What is the salary range at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company?
Most posted roles fall between $193,750 and $272,500, with the full range spanning $150,000 to $380,000.
Does Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company publish salaries?
These figures come from Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company's own job postings (salary ranges disclosed on listings), aggregated by Hireoven. Actual offers vary by level, location and negotiation.
Salary figures are aggregated from disclosed ranges in Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company's active US job postings on Hireoven's live index. Annualized; hourly listings excluded. Actual compensation varies by level, location and negotiation. Last updated 2026.